Lombard Odier Asset Management (USA)’s Cymabay Therapeutics CBAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-145,000	Closed	-$284K	–	302
2019 Q4	$284K	Hold	145,000	–	–	0.04%	219
2019 Q3	$742K	Hold	145,000	–	–	0.11%	193
2019 Q2	$1.04M	Sell	145,000 -35,000	-19%	-$396K	0.12%	166
2019 Q1	$2.39M	Sell	180,000 -39,495	-18%	-$420K	0.31%	111
2018 Q4	$1.73M	Sell	219,495 -78,566	-26%	-$748K	0.24%	143
2018 Q3	$3.3M	Sell	298,061 -80,939	-21%	-$1.01M	0.42%	117
2018 Q2	$5.09M	Sell	379,000 -25,000	-6%	-$313K	0.59%	93
2018 Q1	$5.25M	Sell	404,000 -117,247	-22%	-$1.46M	0.54%	69
2017 Q4	$4.79M	Sell	521,247 -3,753	-0.7%	-$32.1K	0.53%	79
2017 Q3	$4.23M	Sell	525,000 -1,665	-0.3%	-$11.3K	0.45%	93
2017 Q2	$3.03M	Hold	526,665	–	–	0.35%	111
2017 Q1	$2.27M	Sell	526,665 -50,000	-9%	-$143K	0.31%	129
2016 Q4	$998K	Sell	576,665 -50,313	-8%	-$88.8K	0.18%	131
2016 Q3	$1.22M	Sell	626,978 -26,238	-4%	-$52.2K	0.15%	182
2016 Q2	$1.14M	Sell	653,216 -56,224	-8%	-$117K	0.16%	143
2016 Q1	$958K	Sell	709,440 -376,241	-35%	-$466K	0.13%	136
2015 Q4	$1.83M	Sell	1,085,681 -12,517	-1%	-$20.4K	0.18%	119
2015 Q3	$2.13M	Buy	1,098,198 +356,072	+48%	+$969K	0.2%	136
2015 Q2	$2M	Sell	742,126 -568,874	-43%	-$2.34M	0.17%	148
2015 Q1	$9.07M	Sell	1,311,000 -57,557	-4%	-$553K	0.87%	39
2014 Q4	$13.5M	Buy	1,368,557 +118,557	+9%	+$953K	1.24%	27
2014 Q3	$8.55M	Buy	+1,250,000	New	+$7.68M	0.87%	51

Other funds holding CBAY